IN VIVO’s Deals Of The Month: May 2016
IN VIVO’s editors pick May's most significant deals, including a hefty Series A for Homology, Cigna's latest pay-for-performance deals, and a merger of giants. (Article free with registration.)
You may also be interested in...
The wave of merger and acquisitions that has washed through the contract research organization sector this year is set to continue as the pharmaceutical industry increasingly turns to outsourcing for its clinical needs.
Amgen and Sanofi/Regeneron will pay deeper discounts if patients taking Repatha and Praluent don’t experience similar levels of LDL-cholesterol lowering as was seen in clinical trials.
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)